O’Melveny advised Evinced on the transaction. Evinced, the rapidly-growing technology leader in digital accessibility software, closed its US$55 million Series C funding round. The funding round...
You must be a Standard 1 Year member to access this content.
O’Melveny advised EyecareLive on the deal. EyecareLive, a digital vision care service that brings technology to eye doctors, patients, and pharmaceutical companies, announced its merger with...
You must be a Standard 1 Year member to access this content.
O’Melveny advised Superfluid DX on the transaction. Superfluid DX, a San Francisco-based company which specializes in advancing solutions for the diagnosis of Alzheimer’s disease, closed its...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised GreenLight Biosciences, Foley Hoag advised the Special Committee, while O’Melveny & Myers advised Fall Line on the deal. GreenLight Biosciences Holdings, PBC (NASDAQ:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP is serving as legal counsel to the Company. Roth Capital Partners, LLC is serving as financial advisor and Foley Hoag LLP is serving...
You must be a Standard 1 Year member to access this content.
